Ritonavir News and Research

RSS
Ritonavir, also known as Norvir, is a type of medicine called a protease inhibitor (PI). PIs act by blocking protease, a protein that HIV needs to make more copies of itself. Ritonavir was approved by the FDA on March 1, 1996, for use with other antiretroviral agents in the treatment of HIV infection in adults and children 2 years of age or older. Ritonavir is now approved with other anti-HIV drugs in the treatment of HIV-1 infection in children in individuals over 1 month in age. Studies have shown that ritonavir works as a booster for some other PIs. Taking ritonavir makes it possible to take a lower dose of the other PIs. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.
What older Americans need to know about taking Paxlovid

What older Americans need to know about taking Paxlovid

New research on nirmatrelvir resistance in SARS-CoV-2 using powerful replicon cell culture systems

New research on nirmatrelvir resistance in SARS-CoV-2 using powerful replicon cell culture systems

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

What are the long-term outcomes of critical COVID-19 patients?

What are the long-term outcomes of critical COVID-19 patients?

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

The effectiveness of nirmatrelvir-ritonavir and molnupiravir for the treatment of COVID-19 among US veterans

The effectiveness of nirmatrelvir-ritonavir and molnupiravir for the treatment of COVID-19 among US veterans

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

Among US veterans with COVID-19, few used antivirals or monoclonal antibodies

Among US veterans with COVID-19, few used antivirals or monoclonal antibodies

Short-term outcomes in pregnant patients with COVID-19 who received nirmatrelvir–ritonavir treatment

Short-term outcomes in pregnant patients with COVID-19 who received nirmatrelvir–ritonavir treatment

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

What is the role of cyclophilin-A in alleviating SARS-CoV-2 infections?

What is the role of cyclophilin-A in alleviating SARS-CoV-2 infections?

Cohort study determines how often COVID-19 symptoms recurred

Cohort study determines how often COVID-19 symptoms recurred

How does COVID-19 and its treatment affect testicular function?

How does COVID-19 and its treatment affect testicular function?

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Transition in the management of COVID-19

Transition in the management of COVID-19